Clinical Trial Update: Inhalation Flow Rate-study [Phase 1]

View source ↗

Summary

Bayer reported completion of a Phase 1 inhalation flow-rate study in bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Bayer | Conditions: Bronchiectasis | Phase 1 | Status: COMPLETED